The Group to invest a total of USD 21 billion in the U.S. from 2025 to 2028USD 9 billion to…
TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.7…
BRIDGETOWN, Barbados, March 17, 2025 /PRNewswire/ -- The SEforALL Global Forum has witnessed groundbreaking commitments totalling over USD 900 million…
Monmouthshire, UK, March 02, 2025 (GLOBE NEWSWIRE) -- Alr Miner, a leading AI cloud mining platform, is making waves in…
FORT LAUDERDALE, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB US: ZEFIF)…
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is…
TOKYO, Jan. 30, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2…
ABU DHABI, UAE, Dec. 19, 2024 /PRNewswire/ -- ADGM, the leading international financial centre of Abu Dhabi and a globally…
ABU DHABI, UAE, Dec. 19, 2024 /PRNewswire/ -- ADGM, the leading international financial centre of Abu Dhabi and a globally…
TOKYO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that M3, Inc. (TOKYO PRIME:…